STOCK TITAN
  1. Home
  2. Sec-filings
  3. NRXP
  4. [EFFECT] NRX Pharmaceuticals, Inc. SEC Filing

[EFFECT] NRX Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 22, 2025 5:00 P.M.
Form: S-3
CIK: 0001719406
Company Name: NRX Pharmaceuticals, Inc.
File Number: 333-288205

Source: View Original Filing on SEC EDGAR

Stock NRXP logo
Nrx Pharmaceuticals Inc

NASDAQ:NRXP

NRXP Rankings

#5491 Ranked by Market Cap
N/A Ranked by Dividends

NRXP Latest News

Jan 16, 2026
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date
Jan 15, 2026
Bright Mountain Media Showcases Award-Winning Aruba Campaign; CEO Demonstrates Confidence with Stock Acquisition
Jan 14, 2026
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
Jan 5, 2026
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions
Dec 18, 2025
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

NRXP Latest SEC Filings

Feb 2, 2026
[8-K] NRX Pharmaceuticals, Inc. Reports Material Event
Jan 16, 2026
[8-K] NRX Pharmaceuticals, Inc. Reports Material Event
Dec 12, 2025
[S-3/A] NRX Pharmaceuticals, Inc. Amended Shelf Registration Statement
Nov 26, 2025
[8-K] NRX Pharmaceuticals, Inc. Reports Material Event
Nov 21, 2025
[8-K/A] NRX Pharmaceuticals, Inc. Amends Material Event Report

NRXP Stock Data

53.88M
26.86M
11.55%
25.47%
2.66%
Biotechnology
Pharmaceutical Preparations
Link
United States
WILMINGTON